Viewing Study NCT06337695


Ignite Creation Date: 2025-12-24 @ 1:41 PM
Ignite Modification Date: 2025-12-27 @ 10:46 PM
Study NCT ID: NCT06337695
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-02
First Post: 2024-03-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer
Sponsor: University of Calgary
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module